← Companies|atai Life Sciences
AT

atai Life Sciences

ATAI·NASDAQBerlin DEFounded 201860 employees
Small CapbiotechPublicCNS
Platform: Psychedelic Platform
Market Cap
$0.5B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ATAI)
Loading ATAI stock data...
Drug Pipeline (2 programs)
Drug NameCodePhaseTrialsModalityTargetMOAIndications
ATA-3814ATA-3814NDA/BLA2RadioligandCD20PD-1iHCCPompe
DatorapivirATA-7135Phase 2/31Bispecific AbIL-17AC5iHS
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)
2025-02-02
ATA-3814 Ph3 Readout
HS
Past
2026-06-08
Datorapivir Ph3 Readout
HS
Ph3 Readout
2029-08-14
ATA-3814 Ph3 Readout
HS
Ph3 Readout